CYTOKINETICS, INCORPORATED Increase (Decrease) in Accrued Liabilities
CYTOKINETICS, INCORPORATED (CYTK) reported Increase (Decrease) in Accrued Liabilities of -$966.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $5.25M, a 62.48% decline year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$6.21M.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $26.37M, a 161.67% increase year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $7.62M, a 38.21% increase year-over-year.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for fiscal 2025 was $33.60M, a 136.94% increase from fiscal 2024.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for fiscal 2024 was $14.18M, a 17.08% decline from fiscal 2023.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for fiscal 2023 was $17.10M, a 57.72% increase from fiscal 2022.
- CYTOKINETICS, INCORPORATED increase (decrease) in accrued liabilities for fiscal 2022 was $10.84M, a 27.99% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 167 month | Increase (Decrease) in Accrued Liabilities 170 month | Increase (Decrease) in Accrued Liabilities 173 month | Increase (Decrease) in Accrued Liabilities 176 month | Increase (Decrease) in Accrued Liabilities 179 month | Increase (Decrease) in Accrued Liabilities 182 month | Increase (Decrease) in Accrued Liabilities 185 month | Increase (Decrease) in Accrued Liabilities 188 month | Increase (Decrease) in Accrued Liabilities 191 month | Increase (Decrease) in Accrued Liabilities 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$966.00K 10-Q · filed 2026-08-06 | $25.40M derived: sum of 3 quarters · filed 2026-08-06 | $33.02M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2026-03-31 | -$6.21M 10-Q · filed 2026-05-05 | $20.16M derived: sum of 2 quarters · filed 2026-05-05 | $27.77M derived: sum of 3 quarters · filed 2026-05-05 | $41.76M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-12-31 | $26.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.98M derived: sum of 2 quarters · filed 2026-02-26 | $47.97M derived: sum of 3 quarters · filed 2026-08-06 | $33.60M 10-K · filed 2026-02-26 | |||||||||||
| 2025-09-30 | $7.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $21.60M derived: sum of 2 quarters · filed 2026-08-06 | $7.24M 10-Q · filed 2025-11-05 | $17.31M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-06-30 | $13.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$382.00K 10-Q · filed 2026-08-06 | $9.70M derived: sum of 3 quarters · filed 2026-08-06 | $15.21M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-03-31 | -$14.37M 10-Q · filed 2026-05-05 | -$4.29M derived: sum of 2 quarters · filed 2026-05-05 | $1.22M derived: sum of 3 quarters · filed 2026-05-05 | $5.39M derived: sum of 4 quarters · filed 2026-05-05 | |||||||||||
| 2024-12-31 | $10.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.59M derived: sum of 2 quarters · filed 2026-02-26 | $19.76M derived: sum of 3 quarters · filed 2026-02-26 | $14.18M 10-K · filed 2026-02-26 | |||||||||||
| 2024-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.68M derived: sum of 2 quarters · filed 2025-11-05 | $4.11M 10-Q · filed 2025-11-05 | $36.23M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||
| 2024-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.41M 10-Q · filed 2025-08-07 | $30.72M derived: sum of 3 quarters · filed 2026-02-26 | $34.88M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||
| 2024-03-31 | -$5.58M 10-Q · filed 2025-05-06 | $26.55M derived: sum of 2 quarters · filed 2026-02-26 | $30.70M derived: sum of 3 quarters · filed 2026-02-26 | $19.28M derived: sum of 4 quarters · filed 2026-02-26 | |||||||||||
| 2023-12-31 | $32.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.28M derived: sum of 2 quarters · filed 2026-02-26 | $24.86M derived: sum of 3 quarters · filed 2026-02-26 | $17.10M 10-K · filed 2026-02-26 | |||||||||||
| 2023-09-30 | $4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$7.27M derived: sum of 2 quarters · filed 2024-11-07 | -$15.03M 10-Q · filed 2024-11-07 | -$15.38M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||
| 2023-06-30 | -$11.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$19.18M 10-Q · filed 2024-08-09 | -$19.53M derived: sum of 3 quarters · filed 2025-02-27 | -$10.89M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||
| 2023-03-31 | -$7.75M 10-Q · filed 2024-05-10 | -$8.11M derived: sum of 2 quarters · filed 2025-02-27 | $532.00K derived: sum of 3 quarters · filed 2025-02-27 | $6.61M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||
| 2022-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.29M derived: sum of 2 quarters · filed 2025-02-27 | $14.37M derived: sum of 3 quarters · filed 2025-02-27 | $10.84M 10-K · filed 2025-02-27 | |||||||||||
| 2022-09-30 | $8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $14.72M derived: sum of 2 quarters · filed 2023-11-03 | $11.20M 10-Q · filed 2023-11-03 | $12.43M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2022-06-30 | $6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.56M 10-Q · filed 2023-08-03 | $3.80M derived: sum of 3 quarters · filed 2024-02-28 | $14.58M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2022-03-31 | -$3.52M 10-Q · filed 2023-05-05 | -$2.28M derived: sum of 2 quarters · filed 2024-02-28 | $8.50M derived: sum of 3 quarters · filed 2024-02-28 | $14.66M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2021-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $12.03M derived: sum of 2 quarters · filed 2024-02-28 | $18.18M derived: sum of 3 quarters · filed 2024-02-28 | $15.06M 10-K · filed 2024-02-28 | |||||||||||
| 2021-09-30 | $10.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $16.94M derived: sum of 2 quarters · filed 2022-11-04 | $13.82M 10-Q · filed 2022-11-04 | $15.29M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||
| 2021-06-30 | $6.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.03M 10-Q · filed 2022-08-05 | $4.51M derived: sum of 3 quarters · filed 2023-03-01 | $8.70M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||
| 2021-03-31 | -$3.12M 10-Q · filed 2022-05-06 | -$1.65M derived: sum of 2 quarters · filed 2023-03-01 | $2.54M derived: sum of 3 quarters · filed 2023-03-01 | $5.06M derived: sum of 4 quarters · filed 2023-03-01 | |||||||||||
| 2020-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.66M derived: sum of 2 quarters · filed 2023-03-01 | $8.18M derived: sum of 3 quarters · filed 2023-03-01 | $7.12M 10-K · filed 2023-03-01 | |||||||||||
| 2020-09-30 | $4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $6.71M derived: sum of 2 quarters · filed 2021-11-05 | $5.64M 10-Q · filed 2021-11-05 | $5.38M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||
| 2020-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.45M 10-Q · filed 2021-08-06 | $1.19M derived: sum of 3 quarters · filed 2022-02-25 | $2.51M derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||
| 2020-03-31 | -$1.06M 10-Q · filed 2021-05-07 | -$1.33M derived: sum of 2 quarters · filed 2022-02-25 | -$9.00K derived: sum of 3 quarters · filed 2022-02-25 | -$766.00K derived: sum of 4 quarters · filed 2022-02-25 | |||||||||||
| 2019-12-31 | -$265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.05M derived: sum of 2 quarters · filed 2022-02-25 | $298.00K derived: sum of 3 quarters · filed 2022-02-25 | -$2.17M 10-K · filed 2022-02-25 | |||||||||||
| 2019-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $563.00K derived: sum of 2 quarters · filed 2020-11-06 | -$1.90M 10-Q · filed 2020-11-06 | -$1.86M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||
| 2019-06-30 | -$757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$3.22M 10-Q · filed 2020-08-07 | -$3.18M derived: sum of 3 quarters · filed 2021-02-26 | -$3.69M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||
| 2019-03-31 | -$2.47M 10-Q · filed 2020-05-08 | -$2.42M derived: sum of 2 quarters · filed 2021-02-26 | -$2.93M derived: sum of 3 quarters · filed 2021-02-26 | -$5.60M derived: sum of 4 quarters · filed 2021-02-26 | |||||||||||
| 2018-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$466.00K derived: sum of 2 quarters · filed 2021-02-26 | -$3.13M derived: sum of 3 quarters · filed 2021-02-26 | -$2.06M 10-K · filed 2021-02-26 | |||||||||||
| 2018-09-30 | -$512.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$3.18M derived: sum of 2 quarters · filed 2019-11-01 | -$2.11M 10-Q · filed 2019-11-01 | -$1.21M derived: sum of 4 quarters · filed 2019-11-01 | |||||||||||
| 2018-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$1.60M 10-Q · filed 2019-08-09 | -$699.00K derived: sum of 3 quarters · filed 2019-08-09 | $3.08M derived: sum of 4 quarters · filed 2019-08-09 | |||||||||||
| 2018-03-31 | $1.07M 10-Q · filed 2019-05-09 | $1.97M derived: sum of 2 quarters · filed 2019-05-09 | $5.75M derived: sum of 3 quarters · filed 2019-05-09 | $1.68M derived: sum of 4 quarters · filed 2019-05-09 | |||||||||||
| 2017-12-31 | $898.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.68M derived: sum of 2 quarters · filed 2019-03-07 | $615.00K derived: sum of 3 quarters · filed 2019-03-07 | $766.00K 10-K · filed 2019-03-07 | |||||||||||
| 2017-09-30 | $3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$283.00K derived: sum of 2 quarters · filed 2018-11-09 | -$132.00K 10-Q · filed 2018-11-09 | $1.17M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||
| 2017-06-30 | -$4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$3.91M 10-Q · filed 2018-08-07 | -$2.61M derived: sum of 3 quarters · filed 2018-08-07 | $3.89M derived: sum of 4 quarters · filed 2018-08-07 | |||||||||||
| 2017-03-31 | $151.00K 10-Q · filed 2018-05-10 | $1.45M derived: sum of 2 quarters · filed 2018-05-10 | $7.95M derived: sum of 3 quarters · filed 2018-05-10 | $9.46M derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||
| 2016-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $7.80M derived: sum of 2 quarters · filed 2018-03-05 | $9.31M derived: sum of 3 quarters · filed 2018-03-05 | $8.95M 10-K · filed 2018-03-05 | |||||||||||
| 2016-09-30 | $6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $8.01M derived: sum of 2 quarters · filed 2017-11-03 | $7.65M 10-Q · filed 2017-11-03 | $9.12M 10-Q · filed 2016-11-03 | $9.30M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $1.14M 10-Q · filed 2017-08-04 | $2.80M derived: sum of 3 quarters · filed 2018-03-05 | $3.56M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2016-03-31 | -$365.00K 10-Q · filed 2017-05-04 | $1.29M derived: sum of 2 quarters · filed 2018-03-05 | $2.05M derived: sum of 3 quarters · filed 2018-03-05 | $4.05M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2015-12-31 | $1.65M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | $2.41M derived: sum of 2 quarters · filed 2018-03-05 | $4.41M derived: sum of 3 quarters · filed 2018-03-05 | $3.00M 10-K · filed 2018-03-05 | |||||||||||
| 2015-09-30 | $759.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-12-15 | $2.76M derived: sum of 2 quarters · filed 2016-12-15 | $1.34M 10-Q/A · filed 2016-12-15 | $705.00K derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||
| 2015-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $582.00K 10-Q · filed 2016-08-04 | -$54.00K derived: sum of 3 quarters · filed 2017-03-06 | -$958.00K derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||
| 2015-03-31 | -$1.42M 10-Q · filed 2016-05-05 | -$2.05M derived: sum of 2 quarters · filed 2017-03-06 | -$2.96M derived: sum of 3 quarters · filed 2017-03-06 | -$3.72M derived: sum of 4 quarters · filed 2017-03-06 | |||||||||||
| 2014-12-31 | -$636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | -$1.54M derived: sum of 2 quarters · filed 2017-03-06 | -$2.31M derived: sum of 3 quarters · filed 2017-03-06 | -$2.87M 10-K · filed 2017-03-06 | |||||||||||
| 2014-09-30 | -$904.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.67M derived: sum of 2 quarters · filed 2015-11-05 | -$2.23M 10-Q · filed 2015-11-05 | -$3.87M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||
| 2014-06-30 | -$765.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$1.32M 10-Q · filed 2015-08-05 | -$2.96M derived: sum of 3 quarters · filed 2016-03-03 | $240.00K derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||
| 2014-03-31 | -$560.00K 10-Q · filed 2015-05-04 | -$2.20M derived: sum of 2 quarters · filed 2016-03-03 | $1.00M derived: sum of 3 quarters · filed 2016-03-03 | $3.07M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||||
| 2013-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.56M derived: sum of 2 quarters · filed 2016-03-03 | $3.63M derived: sum of 3 quarters · filed 2016-03-03 | $3.52M 10-K · filed 2016-03-03 | |||||||||||
| 2013-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $5.26M derived: sum of 2 quarters · filed 2014-11-06 | $5.16M 10-Q · filed 2014-11-06 | $7.35M derived: sum of 4 quarters · filed 2015-03-06 | $10.17M 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | $2.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.96M 10-Q · filed 2014-08-07 | $4.14M derived: sum of 3 quarters · filed 2015-03-06 | $4.18M derived: sum of 4 quarters · filed 2015-03-06 | $6.96M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | -$103.00K 10-Q · filed 2014-05-07 | $2.08M derived: sum of 2 quarters · filed 2015-03-06 | $2.12M derived: sum of 3 quarters · filed 2015-03-06 | $1.59M derived: sum of 4 quarters · filed 2015-03-06 | $4.90M 10-Q · filed 2013-05-08 | ||||||||||
| 2012-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $2.23M derived: sum of 2 quarters · filed 2015-03-06 | $1.69M derived: sum of 3 quarters · filed 2015-03-06 | $2.10M 10-K · filed 2015-03-06 | $5.00M 10-K · filed 2013-03-15 | ||||||||||
| 2012-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$493.00K derived: sum of 2 quarters · filed 2013-11-06 | -$89.00K 10-Q · filed 2013-11-06 | -$305.00K derived: sum of 4 quarters · filed 2014-03-07 | $2.82M 10-Q · filed 2012-11-07 | ||||||||||
| 2012-06-30 | -$531.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$127.00K 10-Q · filed 2013-08-07 | -$343.00K derived: sum of 3 quarters · filed 2014-03-07 | -$797.00K derived: sum of 4 quarters · filed 2014-03-07 | $2.78M 10-Q · filed 2012-08-06 | ||||||||||
| 2012-03-31 | $404.00K 10-Q · filed 2013-05-08 | $188.00K derived: sum of 2 quarters · filed 2014-03-07 | -$266.00K derived: sum of 3 quarters · filed 2014-03-07 | -$758.00K derived: sum of 4 quarters · filed 2014-03-07 | $3.31M 10-Q · filed 2012-05-04 | ||||||||||
| 2011-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$670.00K derived: sum of 2 quarters · filed 2014-03-07 | -$1.16M derived: sum of 3 quarters · filed 2014-03-07 | -$2.27M 10-K · filed 2014-03-07 | $2.91M 10-K · filed 2012-03-13 | ||||||||||
| 2011-09-30 | -$454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$946.00K derived: sum of 2 quarters · filed 2012-11-07 | -$2.05M 10-Q · filed 2012-11-07 | -$1.19M derived: sum of 4 quarters · filed 2013-03-15 | $3.12M 10-Q · filed 2011-11-04 | ||||||||||
| 2011-06-30 | -$492.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | -$1.60M 10-Q · filed 2012-08-06 | -$737.00K derived: sum of 3 quarters · filed 2013-03-15 | -$721.00K derived: sum of 4 quarters · filed 2013-03-15 | $3.58M 10-Q · filed 2011-08-04 | ||||||||||
| 2011-03-31 | -$1.10M 10-Q · filed 2012-05-04 | -$245.00K derived: sum of 2 quarters · filed 2013-03-15 | -$229.00K derived: sum of 3 quarters · filed 2013-03-15 | ||||||||||||
| 2010-12-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $875.00K derived: sum of 2 quarters · filed 2013-03-15 | -$627.00K 10-K · filed 2013-03-15 | ||||||||||||
| 2010-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$1.49M 10-Q · filed 2011-11-04 | |||||||||||||
| 2010-06-30 | -$1.50M 10-Q · filed 2011-08-04 | ||||||||||||||
| 2009-12-31 | -$1.18M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |